Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.21.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Schedule Of Cash Flow Supplemental [Line Items]    
Cash paid for interest $ 22,285 $ 8,774
Cash paid (refunds received) for income taxes, net (1,946) 2,110
Cash deposited in restricted accounts [1] 7,300  
Noncash investing and financing activities:    
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [2] (6,955) 2,269
Investment in NCM – receipt of common units   3,620
Dividends accrued on unvested restricted stock unit awards (2) (256) [3]
NCM    
Noncash investing and financing activities:    
Interest expense - NCM (see Note 9) $ (5,835) $ (5,891)
[1] Represents cash deposited in a collateral account during the period to support the issuance of letters of credit to lenders.  See further discussion at Note 7.
[2] Additions to theatre properties and equipment included in accounts payable as of March 31, 2021 and December 31, 2020 were $21,295 and $28,250, respectively.
[3] On March 20, 2020 the Company paid a $0.36 dividend per common share to stockholders of record on March 6, 2020.  Additionally, the Company accrued dividends on outstanding unvested restricted stock units.